Stock NLSP NLS PHARMACEUTICS AG
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart NLS Pharmaceutics AG

Equities

NLSP

CH0523961370

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-06-06 EDT 		5-day change 1st Jan Change
0.1318 USD -3.09% Intraday chart for NLS Pharmaceutics AG -20.70% -77.66%
05-22 NLS Pharmaceutics Ltd. Enters into Additional Bridge Loan Addendums, or the Second Bridge Loan Addendums CI
05-15 NLS Pharmaceutics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
NLS PHARMACEUTICS AG Stock NLS Pharmaceutics AG
 6.21M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 59.28B -
LONZA GROUP AG Stock Lonza Group AG
 40.94B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 40.17B
CELLTRION, INC. Stock Celltrion, Inc.
 28.69B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.63B
  1. Stock Market
  2. Equities
  3. NLSP Stock
  4. Charts NLS Pharmaceutics AG
  5. Sector Chart